nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—CYP3A4—Temozolomide—brain cancer	0.127	0.487	CbGbCtD
Levonorgestrel—CYP3A4—Lomustine—brain cancer	0.108	0.414	CbGbCtD
Levonorgestrel—CYP3A4—Etoposide—brain cancer	0.0262	0.1	CbGbCtD
Levonorgestrel—SRD5A1—telencephalon—brain cancer	0.0119	0.0693	CbGeAlD
Levonorgestrel—SRD5A1—gonad—brain cancer	0.00996	0.0578	CbGeAlD
Levonorgestrel—SHBG—hindbrain—brain cancer	0.00855	0.0496	CbGeAlD
Levonorgestrel—PGR—blood vessel—brain cancer	0.00807	0.0468	CbGeAlD
Levonorgestrel—PGR—hindbrain—brain cancer	0.0077	0.0447	CbGeAlD
Levonorgestrel—SRD5A1—endocrine gland—brain cancer	0.00753	0.0437	CbGeAlD
Levonorgestrel—SRD5A1—head—brain cancer	0.00743	0.0431	CbGeAlD
Levonorgestrel—SRD5A1—central nervous system—brain cancer	0.00679	0.0394	CbGeAlD
Levonorgestrel—ESR1—blood vessel—brain cancer	0.00631	0.0366	CbGeAlD
Levonorgestrel—ESR1—hindbrain—brain cancer	0.00602	0.0349	CbGeAlD
Levonorgestrel—SRD5A1—brain—brain cancer	0.00539	0.0313	CbGeAlD
Levonorgestrel—SHBG—brainstem—brain cancer	0.0049	0.0284	CbGeAlD
Levonorgestrel—Mestranol—CYP2C9—brain cancer	0.00477	0.47	CrCbGaD
Levonorgestrel—SHBG—gonad—brain cancer	0.00363	0.021	CbGeAlD
Levonorgestrel—SHBG—pituitary gland—brain cancer	0.00354	0.0205	CbGeAlD
Levonorgestrel—ESR1—brainstem—brain cancer	0.00345	0.02	CbGeAlD
Levonorgestrel—PGR—pituitary gland—brain cancer	0.00319	0.0185	CbGeAlD
Levonorgestrel—AR—telencephalon—brain cancer	0.00312	0.0181	CbGeAlD
Levonorgestrel—ESR1—telencephalon—brain cancer	0.00306	0.0178	CbGeAlD
Levonorgestrel—CYP19A1—gonad—brain cancer	0.00294	0.0171	CbGeAlD
Levonorgestrel—Ethinyl Estradiol—ESR2—brain cancer	0.0029	0.285	CrCbGaD
Levonorgestrel—SHBG—endocrine gland—brain cancer	0.00274	0.0159	CbGeAlD
Levonorgestrel—AR—gonad—brain cancer	0.0026	0.0151	CbGeAlD
Levonorgestrel—ESR1—gonad—brain cancer	0.00256	0.0148	CbGeAlD
Levonorgestrel—AR—pituitary gland—brain cancer	0.00254	0.0147	CbGeAlD
Levonorgestrel—ESR1—pituitary gland—brain cancer	0.00249	0.0145	CbGeAlD
Levonorgestrel—SHBG—central nervous system—brain cancer	0.00247	0.0143	CbGeAlD
Levonorgestrel—PGR—endocrine gland—brain cancer	0.00247	0.0143	CbGeAlD
Levonorgestrel—PGR—head—brain cancer	0.00244	0.0141	CbGeAlD
Levonorgestrel—SHBG—cerebellum—brain cancer	0.00242	0.014	CbGeAlD
Levonorgestrel—Abnormal vision—Temozolomide—brain cancer	0.00224	0.00552	CcSEcCtD
Levonorgestrel—PGR—central nervous system—brain cancer	0.00223	0.0129	CbGeAlD
Levonorgestrel—CYP19A1—endocrine gland—brain cancer	0.00222	0.0129	CbGeAlD
Levonorgestrel—CYP19A1—head—brain cancer	0.00219	0.0127	CbGeAlD
Levonorgestrel—AR—spinal cord—brain cancer	0.00219	0.0127	CbGeAlD
Levonorgestrel—PGR—cerebellum—brain cancer	0.00218	0.0126	CbGeAlD
Levonorgestrel—Body temperature increased—Carboplatin—brain cancer	0.00216	0.00532	CcSEcCtD
Levonorgestrel—Breast disorder—Hydroxyurea—brain cancer	0.00216	0.00531	CcSEcCtD
Levonorgestrel—Haemoglobin—Procarbazine—brain cancer	0.00214	0.00528	CcSEcCtD
Levonorgestrel—Haemorrhage—Procarbazine—brain cancer	0.00213	0.00526	CcSEcCtD
Levonorgestrel—Vascular purpura—Temozolomide—brain cancer	0.00208	0.00514	CcSEcCtD
Levonorgestrel—Decreased appetite—Lomustine—brain cancer	0.00208	0.00511	CcSEcCtD
Levonorgestrel—CYP19A1—central nervous system—brain cancer	0.002	0.0116	CbGeAlD
Levonorgestrel—AR—endocrine gland—brain cancer	0.00197	0.0114	CbGeAlD
Levonorgestrel—Candida infection—Etoposide—brain cancer	0.00196	0.00484	CcSEcCtD
Levonorgestrel—SHBG—brain—brain cancer	0.00196	0.0114	CbGeAlD
Levonorgestrel—AR—head—brain cancer	0.00194	0.0113	CbGeAlD
Levonorgestrel—Purpura—Temozolomide—brain cancer	0.00193	0.00477	CcSEcCtD
Levonorgestrel—ESR1—endocrine gland—brain cancer	0.00193	0.0112	CbGeAlD
Levonorgestrel—Dysuria—Hydroxyurea—brain cancer	0.00193	0.00475	CcSEcCtD
Levonorgestrel—ESR1—head—brain cancer	0.00191	0.0111	CbGeAlD
Levonorgestrel—Arrhythmia—Procarbazine—brain cancer	0.00191	0.0047	CcSEcCtD
Levonorgestrel—Body temperature increased—Lomustine—brain cancer	0.00189	0.00465	CcSEcCtD
Levonorgestrel—Alopecia—Procarbazine—brain cancer	0.00189	0.00465	CcSEcCtD
Levonorgestrel—Weight increased—Hydroxyurea—brain cancer	0.00188	0.00463	CcSEcCtD
Levonorgestrel—Infestation NOS—Hydroxyurea—brain cancer	0.00184	0.00453	CcSEcCtD
Levonorgestrel—Infestation—Hydroxyurea—brain cancer	0.00184	0.00453	CcSEcCtD
Levonorgestrel—Affect lability—Temozolomide—brain cancer	0.00184	0.00452	CcSEcCtD
Levonorgestrel—Tension—Procarbazine—brain cancer	0.00182	0.00449	CcSEcCtD
Levonorgestrel—Nervousness—Procarbazine—brain cancer	0.0018	0.00444	CcSEcCtD
Levonorgestrel—AR—central nervous system—brain cancer	0.00177	0.0103	CbGeAlD
Levonorgestrel—PGR—brain—brain cancer	0.00177	0.0103	CbGeAlD
Levonorgestrel—Mood swings—Temozolomide—brain cancer	0.00177	0.00435	CcSEcCtD
Levonorgestrel—ESR1—central nervous system—brain cancer	0.00174	0.0101	CbGeAlD
Levonorgestrel—Anaemia—Procarbazine—brain cancer	0.00172	0.00423	CcSEcCtD
Levonorgestrel—Dry skin—Temozolomide—brain cancer	0.00171	0.00421	CcSEcCtD
Levonorgestrel—ESR1—cerebellum—brain cancer	0.0017	0.00987	CbGeAlD
Levonorgestrel—Breast disorder—Temozolomide—brain cancer	0.00168	0.00415	CcSEcCtD
Levonorgestrel—Syncope—Procarbazine—brain cancer	0.00167	0.0041	CcSEcCtD
Levonorgestrel—Haemoglobin—Hydroxyurea—brain cancer	0.00166	0.00409	CcSEcCtD
Levonorgestrel—Haemorrhage—Hydroxyurea—brain cancer	0.00165	0.00407	CcSEcCtD
Levonorgestrel—Loss of consciousness—Procarbazine—brain cancer	0.00163	0.00402	CcSEcCtD
Levonorgestrel—Abdominal distension—Temozolomide—brain cancer	0.00162	0.004	CcSEcCtD
Levonorgestrel—Cough—Procarbazine—brain cancer	0.00162	0.00399	CcSEcCtD
Levonorgestrel—Hypertension—Procarbazine—brain cancer	0.0016	0.00395	CcSEcCtD
Levonorgestrel—CYP19A1—brain—brain cancer	0.00159	0.00923	CbGeAlD
Levonorgestrel—Myalgia—Procarbazine—brain cancer	0.00158	0.0039	CcSEcCtD
Levonorgestrel—Anxiety—Procarbazine—brain cancer	0.00158	0.00388	CcSEcCtD
Levonorgestrel—Sweating increased—Temozolomide—brain cancer	0.00157	0.00387	CcSEcCtD
Levonorgestrel—Bronchitis—Temozolomide—brain cancer	0.00155	0.00382	CcSEcCtD
Levonorgestrel—Vomiting—Lomustine—brain cancer	0.00152	0.00374	CcSEcCtD
Levonorgestrel—Oedema—Procarbazine—brain cancer	0.00152	0.00374	CcSEcCtD
Levonorgestrel—Dysuria—Temozolomide—brain cancer	0.00151	0.00371	CcSEcCtD
Levonorgestrel—Infection—Procarbazine—brain cancer	0.00151	0.00371	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Temozolomide—brain cancer	0.0015	0.00369	CcSEcCtD
Levonorgestrel—Pneumonia—Carmustine—brain cancer	0.0015	0.00369	CcSEcCtD
Levonorgestrel—Shock—Procarbazine—brain cancer	0.00149	0.00367	CcSEcCtD
Levonorgestrel—Pollakiuria—Temozolomide—brain cancer	0.00149	0.00367	CcSEcCtD
Levonorgestrel—Depression—Carmustine—brain cancer	0.00148	0.00365	CcSEcCtD
Levonorgestrel—Weight increased—Temozolomide—brain cancer	0.00147	0.00361	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Procarbazine—brain cancer	0.00147	0.00361	CcSEcCtD
Levonorgestrel—Alopecia—Hydroxyurea—brain cancer	0.00146	0.0036	CcSEcCtD
Levonorgestrel—Weight decreased—Temozolomide—brain cancer	0.00146	0.00359	CcSEcCtD
Levonorgestrel—Urinary tract infection—Carmustine—brain cancer	0.00145	0.00356	CcSEcCtD
Levonorgestrel—Pneumonia—Temozolomide—brain cancer	0.00145	0.00356	CcSEcCtD
Levonorgestrel—Anorexia—Procarbazine—brain cancer	0.00144	0.00356	CcSEcCtD
Levonorgestrel—Erythema—Hydroxyurea—brain cancer	0.00144	0.00354	CcSEcCtD
Levonorgestrel—Infestation NOS—Temozolomide—brain cancer	0.00144	0.00354	CcSEcCtD
Levonorgestrel—Infestation—Temozolomide—brain cancer	0.00144	0.00354	CcSEcCtD
Levonorgestrel—Depression—Temozolomide—brain cancer	0.00143	0.00353	CcSEcCtD
Levonorgestrel—Nausea—Lomustine—brain cancer	0.00142	0.00349	CcSEcCtD
Levonorgestrel—AR—brain—brain cancer	0.00141	0.00817	CbGeAlD
Levonorgestrel—Urinary tract infection—Temozolomide—brain cancer	0.0014	0.00344	CcSEcCtD
Levonorgestrel—ESR1—brain—brain cancer	0.00138	0.00802	CbGeAlD
Levonorgestrel—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00138	0.0034	CcSEcCtD
Levonorgestrel—Insomnia—Procarbazine—brain cancer	0.00137	0.00338	CcSEcCtD
Levonorgestrel—Sinusitis—Temozolomide—brain cancer	0.00135	0.00332	CcSEcCtD
Levonorgestrel—Somnolence—Procarbazine—brain cancer	0.00135	0.00332	CcSEcCtD
Levonorgestrel—Haemoglobin—Carmustine—brain cancer	0.00134	0.00331	CcSEcCtD
Levonorgestrel—Haemorrhage—Carmustine—brain cancer	0.00133	0.00329	CcSEcCtD
Levonorgestrel—Anaemia—Hydroxyurea—brain cancer	0.00133	0.00327	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Carmustine—brain cancer	0.00133	0.00327	CcSEcCtD
Levonorgestrel—Decreased appetite—Procarbazine—brain cancer	0.00132	0.00325	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Carmustine—brain cancer	0.00131	0.00323	CcSEcCtD
Levonorgestrel—Fatigue—Procarbazine—brain cancer	0.00131	0.00322	CcSEcCtD
Levonorgestrel—Haemoglobin—Temozolomide—brain cancer	0.0013	0.00319	CcSEcCtD
Levonorgestrel—Pain—Procarbazine—brain cancer	0.0013	0.00319	CcSEcCtD
Levonorgestrel—Constipation—Procarbazine—brain cancer	0.0013	0.00319	CcSEcCtD
Levonorgestrel—Haemorrhage—Temozolomide—brain cancer	0.00129	0.00318	CcSEcCtD
Levonorgestrel—Visual impairment—Carmustine—brain cancer	0.00129	0.00317	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Temozolomide—brain cancer	0.00128	0.00316	CcSEcCtD
Levonorgestrel—Pharyngitis—Temozolomide—brain cancer	0.00128	0.00315	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Temozolomide—brain cancer	0.00127	0.00314	CcSEcCtD
Levonorgestrel—Progesterone—CYP2C9—brain cancer	0.00127	0.126	CrCbGaD
Levonorgestrel—Connective tissue disorder—Temozolomide—brain cancer	0.00127	0.00312	CcSEcCtD
Levonorgestrel—Urethral disorder—Temozolomide—brain cancer	0.00126	0.00312	CcSEcCtD
Levonorgestrel—Sweating increased—Etoposide—brain cancer	0.00126	0.0031	CcSEcCtD
Levonorgestrel—Eye disorder—Carmustine—brain cancer	0.00125	0.00307	CcSEcCtD
Levonorgestrel—Visual impairment—Temozolomide—brain cancer	0.00124	0.00306	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Procarbazine—brain cancer	0.00124	0.00305	CcSEcCtD
Levonorgestrel—Erythema multiforme—Temozolomide—brain cancer	0.00122	0.00301	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00122	0.00299	CcSEcCtD
Levonorgestrel—Discomfort—Hydroxyurea—brain cancer	0.00121	0.00298	CcSEcCtD
Levonorgestrel—Eye disorder—Temozolomide—brain cancer	0.00121	0.00297	CcSEcCtD
Levonorgestrel—Urticaria—Procarbazine—brain cancer	0.0012	0.00297	CcSEcCtD
Levonorgestrel—Testosterone—CYP2C9—brain cancer	0.0012	0.119	CrCbGaD
Levonorgestrel—Abdominal pain—Procarbazine—brain cancer	0.0012	0.00295	CcSEcCtD
Levonorgestrel—Body temperature increased—Procarbazine—brain cancer	0.0012	0.00295	CcSEcCtD
Levonorgestrel—Cardiac disorder—Temozolomide—brain cancer	0.0012	0.00295	CcSEcCtD
Levonorgestrel—Arrhythmia—Carmustine—brain cancer	0.00119	0.00294	CcSEcCtD
Levonorgestrel—Alopecia—Carmustine—brain cancer	0.00118	0.00291	CcSEcCtD
Levonorgestrel—Oedema—Hydroxyurea—brain cancer	0.00117	0.00289	CcSEcCtD
Levonorgestrel—Mental disorder—Carmustine—brain cancer	0.00117	0.00288	CcSEcCtD
Levonorgestrel—Infection—Hydroxyurea—brain cancer	0.00117	0.00287	CcSEcCtD
Levonorgestrel—Immune system disorder—Temozolomide—brain cancer	0.00116	0.00287	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Temozolomide—brain cancer	0.00116	0.00286	CcSEcCtD
Levonorgestrel—Malnutrition—Carmustine—brain cancer	0.00116	0.00286	CcSEcCtD
Levonorgestrel—Erythema—Carmustine—brain cancer	0.00116	0.00286	CcSEcCtD
Levonorgestrel—Pneumonia—Etoposide—brain cancer	0.00116	0.00285	CcSEcCtD
Levonorgestrel—Nervous system disorder—Hydroxyurea—brain cancer	0.00115	0.00283	CcSEcCtD
Levonorgestrel—Infestation NOS—Etoposide—brain cancer	0.00115	0.00283	CcSEcCtD
Levonorgestrel—Infestation—Etoposide—brain cancer	0.00115	0.00283	CcSEcCtD
Levonorgestrel—Alopecia—Temozolomide—brain cancer	0.00114	0.00281	CcSEcCtD
Levonorgestrel—Skin disorder—Hydroxyurea—brain cancer	0.00114	0.00281	CcSEcCtD
Levonorgestrel—Mental disorder—Temozolomide—brain cancer	0.00113	0.00278	CcSEcCtD
Levonorgestrel—Back pain—Carmustine—brain cancer	0.00112	0.00277	CcSEcCtD
Levonorgestrel—Erythema—Temozolomide—brain cancer	0.00112	0.00277	CcSEcCtD
Levonorgestrel—Malnutrition—Temozolomide—brain cancer	0.00112	0.00277	CcSEcCtD
Levonorgestrel—Anorexia—Hydroxyurea—brain cancer	0.00112	0.00276	CcSEcCtD
Levonorgestrel—Hypersensitivity—Procarbazine—brain cancer	0.00112	0.00275	CcSEcCtD
Levonorgestrel—Asthenia—Procarbazine—brain cancer	0.00109	0.00268	CcSEcCtD
Levonorgestrel—Back pain—Temozolomide—brain cancer	0.00109	0.00268	CcSEcCtD
Levonorgestrel—CYP3A4—endocrine gland—brain cancer	0.00108	0.00625	CbGeAlD
Levonorgestrel—Anaemia—Carmustine—brain cancer	0.00107	0.00265	CcSEcCtD
Levonorgestrel—Pruritus—Procarbazine—brain cancer	0.00107	0.00264	CcSEcCtD
Levonorgestrel—Dyspnoea—Hydroxyurea—brain cancer	0.00105	0.00258	CcSEcCtD
Levonorgestrel—Somnolence—Hydroxyurea—brain cancer	0.00104	0.00257	CcSEcCtD
Levonorgestrel—Anaemia—Temozolomide—brain cancer	0.00104	0.00256	CcSEcCtD
Levonorgestrel—Diarrhoea—Procarbazine—brain cancer	0.00104	0.00256	CcSEcCtD
Levonorgestrel—Dyspepsia—Hydroxyurea—brain cancer	0.00103	0.00254	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Etoposide—brain cancer	0.00103	0.00253	CcSEcCtD
Levonorgestrel—Angioedema—Temozolomide—brain cancer	0.00103	0.00253	CcSEcCtD
Levonorgestrel—Decreased appetite—Hydroxyurea—brain cancer	0.00102	0.00251	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Etoposide—brain cancer	0.00102	0.00251	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00101	0.0025	CcSEcCtD
Levonorgestrel—Urethral disorder—Etoposide—brain cancer	0.00101	0.00249	CcSEcCtD
Levonorgestrel—Fatigue—Hydroxyurea—brain cancer	0.00101	0.00249	CcSEcCtD
Levonorgestrel—Vertigo—Temozolomide—brain cancer	0.00101	0.00249	CcSEcCtD
Levonorgestrel—Hypertension—Carmustine—brain cancer	0.001	0.00247	CcSEcCtD
Levonorgestrel—Constipation—Hydroxyurea—brain cancer	0.001	0.00247	CcSEcCtD
Levonorgestrel—Pain—Hydroxyurea—brain cancer	0.001	0.00247	CcSEcCtD
Levonorgestrel—Dizziness—Procarbazine—brain cancer	0.001	0.00247	CcSEcCtD
Levonorgestrel—Palpitations—Temozolomide—brain cancer	0.000992	0.00245	CcSEcCtD
Levonorgestrel—Chest pain—Carmustine—brain cancer	0.000989	0.00244	CcSEcCtD
Levonorgestrel—Myalgia—Carmustine—brain cancer	0.000989	0.00244	CcSEcCtD
Levonorgestrel—Anxiety—Carmustine—brain cancer	0.000986	0.00243	CcSEcCtD
Levonorgestrel—Cough—Temozolomide—brain cancer	0.00098	0.00241	CcSEcCtD
Levonorgestrel—Erythema multiforme—Etoposide—brain cancer	0.000976	0.0024	CcSEcCtD
Levonorgestrel—CYP3A4—central nervous system—brain cancer	0.000971	0.00564	CbGeAlD
Levonorgestrel—Hypertension—Temozolomide—brain cancer	0.000969	0.00239	CcSEcCtD
Levonorgestrel—Eye disorder—Etoposide—brain cancer	0.000965	0.00238	CcSEcCtD
Levonorgestrel—Vomiting—Procarbazine—brain cancer	0.000964	0.00237	CcSEcCtD
Levonorgestrel—Cardiac disorder—Etoposide—brain cancer	0.000958	0.00236	CcSEcCtD
Levonorgestrel—Myalgia—Temozolomide—brain cancer	0.000956	0.00236	CcSEcCtD
Levonorgestrel—Rash—Procarbazine—brain cancer	0.000956	0.00236	CcSEcCtD
Levonorgestrel—Dermatitis—Procarbazine—brain cancer	0.000955	0.00235	CcSEcCtD
Levonorgestrel—Anxiety—Temozolomide—brain cancer	0.000953	0.00235	CcSEcCtD
Levonorgestrel—Headache—Procarbazine—brain cancer	0.000949	0.00234	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000949	0.00234	CcSEcCtD
Levonorgestrel—Oedema—Carmustine—brain cancer	0.000948	0.00234	CcSEcCtD
Levonorgestrel—Discomfort—Temozolomide—brain cancer	0.000944	0.00233	CcSEcCtD
Levonorgestrel—Infection—Carmustine—brain cancer	0.000942	0.00232	CcSEcCtD
Levonorgestrel—Immune system disorder—Etoposide—brain cancer	0.000932	0.0023	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Etoposide—brain cancer	0.00093	0.00229	CcSEcCtD
Levonorgestrel—Body temperature increased—Hydroxyurea—brain cancer	0.000927	0.00229	CcSEcCtD
Levonorgestrel—Oedema—Temozolomide—brain cancer	0.000916	0.00226	CcSEcCtD
Levonorgestrel—Alopecia—Etoposide—brain cancer	0.000912	0.00225	CcSEcCtD
Levonorgestrel—Infection—Temozolomide—brain cancer	0.00091	0.00224	CcSEcCtD
Levonorgestrel—Anorexia—Carmustine—brain cancer	0.000904	0.00223	CcSEcCtD
Levonorgestrel—Nausea—Procarbazine—brain cancer	0.0009	0.00222	CcSEcCtD
Levonorgestrel—Nervous system disorder—Temozolomide—brain cancer	0.000899	0.00221	CcSEcCtD
Levonorgestrel—Skin disorder—Temozolomide—brain cancer	0.00089	0.00219	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—CYP2C9—brain cancer	0.000886	0.0059	CbGpPWpGaD
Levonorgestrel—Hyperhidrosis—Temozolomide—brain cancer	0.000886	0.00218	CcSEcCtD
Levonorgestrel—ESR1—FOXM1 transcription factor network—CDK4—brain cancer	0.000876	0.00584	CbGpPWpGaD
Levonorgestrel—Anorexia—Temozolomide—brain cancer	0.000873	0.00215	CcSEcCtD
Levonorgestrel—Back pain—Etoposide—brain cancer	0.000869	0.00214	CcSEcCtD
Levonorgestrel—Hypersensitivity—Hydroxyurea—brain cancer	0.000864	0.00213	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Carmustine—brain cancer	0.000864	0.00213	CcSEcCtD
Levonorgestrel—Muscle spasms—Etoposide—brain cancer	0.000864	0.00213	CcSEcCtD
Levonorgestrel—Insomnia—Carmustine—brain cancer	0.000858	0.00211	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—HES1—brain cancer	0.000851	0.00567	CbGpPWpGaD
Levonorgestrel—Dyspnoea—Carmustine—brain cancer	0.000845	0.00208	CcSEcCtD
Levonorgestrel—Somnolence—Carmustine—brain cancer	0.000843	0.00208	CcSEcCtD
Levonorgestrel—Asthenia—Hydroxyurea—brain cancer	0.000842	0.00207	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000835	0.00206	CcSEcCtD
Levonorgestrel—Anaemia—Etoposide—brain cancer	0.00083	0.00205	CcSEcCtD
Levonorgestrel—Insomnia—Temozolomide—brain cancer	0.000829	0.00204	CcSEcCtD
Levonorgestrel—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.000825	0.00549	CbGpPWpGaD
Levonorgestrel—Decreased appetite—Carmustine—brain cancer	0.000824	0.00203	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Carmustine—brain cancer	0.000819	0.00202	CcSEcCtD
Levonorgestrel—Dyspnoea—Temozolomide—brain cancer	0.000817	0.00201	CcSEcCtD
Levonorgestrel—Somnolence—Temozolomide—brain cancer	0.000815	0.00201	CcSEcCtD
Levonorgestrel—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.000815	0.00543	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—GFAP—brain cancer	0.000813	0.00541	CbGpPWpGaD
Levonorgestrel—Pain—Carmustine—brain cancer	0.000811	0.002	CcSEcCtD
Levonorgestrel—Constipation—Carmustine—brain cancer	0.000811	0.002	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—PDGFRA—brain cancer	0.000811	0.0054	CbGpPWpGaD
Levonorgestrel—Vertigo—Etoposide—brain cancer	0.000807	0.00199	CcSEcCtD
Levonorgestrel—Dyspepsia—Temozolomide—brain cancer	0.000807	0.00199	CcSEcCtD
Levonorgestrel—Diarrhoea—Hydroxyurea—brain cancer	0.000803	0.00198	CcSEcCtD
Levonorgestrel—Decreased appetite—Temozolomide—brain cancer	0.000797	0.00196	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Temozolomide—brain cancer	0.000791	0.00195	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—VAV1—brain cancer	0.000791	0.00527	CbGpPWpGaD
Levonorgestrel—Fatigue—Temozolomide—brain cancer	0.00079	0.00195	CcSEcCtD
Levonorgestrel—Loss of consciousness—Etoposide—brain cancer	0.00079	0.00195	CcSEcCtD
Levonorgestrel—Cough—Etoposide—brain cancer	0.000784	0.00193	CcSEcCtD
Levonorgestrel—Pain—Temozolomide—brain cancer	0.000784	0.00193	CcSEcCtD
Levonorgestrel—Constipation—Temozolomide—brain cancer	0.000784	0.00193	CcSEcCtD
Levonorgestrel—Hypertension—Etoposide—brain cancer	0.000776	0.00191	CcSEcCtD
Levonorgestrel—Dizziness—Hydroxyurea—brain cancer	0.000776	0.00191	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Carmustine—brain cancer	0.000775	0.00191	CcSEcCtD
Levonorgestrel—Chest pain—Etoposide—brain cancer	0.000765	0.00189	CcSEcCtD
Levonorgestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000762	0.00508	CbGpPWpGaD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00076	0.00187	CcSEcCtD
Levonorgestrel—Discomfort—Etoposide—brain cancer	0.000756	0.00186	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—BSG—brain cancer	0.000753	0.00502	CbGpPWpGaD
Levonorgestrel—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000752	0.00501	CbGpPWpGaD
Levonorgestrel—Body temperature increased—Carmustine—brain cancer	0.00075	0.00185	CcSEcCtD
Levonorgestrel—Abdominal pain—Carmustine—brain cancer	0.00075	0.00185	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Temozolomide—brain cancer	0.000749	0.00185	CcSEcCtD
Levonorgestrel—Vomiting—Hydroxyurea—brain cancer	0.000746	0.00184	CcSEcCtD
Levonorgestrel—Rash—Hydroxyurea—brain cancer	0.00074	0.00182	CcSEcCtD
Levonorgestrel—Dermatitis—Hydroxyurea—brain cancer	0.000739	0.00182	CcSEcCtD
Levonorgestrel—Headache—Hydroxyurea—brain cancer	0.000735	0.00181	CcSEcCtD
Levonorgestrel—Infection—Etoposide—brain cancer	0.000728	0.0018	CcSEcCtD
Levonorgestrel—Urticaria—Temozolomide—brain cancer	0.000728	0.00179	CcSEcCtD
Levonorgestrel—Abdominal pain—Temozolomide—brain cancer	0.000724	0.00179	CcSEcCtD
Levonorgestrel—Body temperature increased—Temozolomide—brain cancer	0.000724	0.00179	CcSEcCtD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.000724	0.00482	CbGpPWpGaD
Levonorgestrel—Skin disorder—Etoposide—brain cancer	0.000712	0.00176	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Etoposide—brain cancer	0.000709	0.00175	CcSEcCtD
Levonorgestrel—Anorexia—Etoposide—brain cancer	0.000699	0.00172	CcSEcCtD
Levonorgestrel—Hypersensitivity—Carmustine—brain cancer	0.000699	0.00172	CcSEcCtD
Levonorgestrel—Nausea—Hydroxyurea—brain cancer	0.000697	0.00172	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000695	0.00463	CbGpPWpGaD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000688	0.00458	CbGpPWpGaD
Levonorgestrel—Asthenia—Carmustine—brain cancer	0.00068	0.00168	CcSEcCtD
Levonorgestrel—Hypersensitivity—Temozolomide—brain cancer	0.000675	0.00166	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000673	0.00448	CbGpPWpGaD
Levonorgestrel—ESR1—FOXM1 transcription factor network—CDKN2A—brain cancer	0.00067	0.00446	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—CDK4—brain cancer	0.000668	0.00445	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000659	0.00439	CbGpPWpGaD
Levonorgestrel—Asthenia—Temozolomide—brain cancer	0.000657	0.00162	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000654	0.00435	CbGpPWpGaD
Levonorgestrel—Dyspnoea—Etoposide—brain cancer	0.000654	0.00161	CcSEcCtD
Levonorgestrel—Somnolence—Etoposide—brain cancer	0.000652	0.00161	CcSEcCtD
Levonorgestrel—Diarrhoea—Carmustine—brain cancer	0.000649	0.0016	CcSEcCtD
Levonorgestrel—Pruritus—Temozolomide—brain cancer	0.000648	0.0016	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—PDGFRA—brain cancer	0.000648	0.00431	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—IDH1—brain cancer	0.000648	0.00431	CbGpPWpGaD
Levonorgestrel—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000648	0.00431	CbGpPWpGaD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.000645	0.0043	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.000639	0.00426	CbGpPWpGaD
Levonorgestrel—Decreased appetite—Etoposide—brain cancer	0.000637	0.00157	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Etoposide—brain cancer	0.000633	0.00156	CcSEcCtD
Levonorgestrel—Fatigue—Etoposide—brain cancer	0.000632	0.00156	CcSEcCtD
Levonorgestrel—Dizziness—Carmustine—brain cancer	0.000627	0.00155	CcSEcCtD
Levonorgestrel—Pain—Etoposide—brain cancer	0.000627	0.00155	CcSEcCtD
Levonorgestrel—Constipation—Etoposide—brain cancer	0.000627	0.00155	CcSEcCtD
Levonorgestrel—Diarrhoea—Temozolomide—brain cancer	0.000627	0.00155	CcSEcCtD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000618	0.00412	CbGpPWpGaD
Levonorgestrel—Dizziness—Temozolomide—brain cancer	0.000606	0.00149	CcSEcCtD
Levonorgestrel—Vomiting—Carmustine—brain cancer	0.000603	0.00149	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Etoposide—brain cancer	0.0006	0.00148	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000599	0.00399	CbGpPWpGaD
Levonorgestrel—Rash—Carmustine—brain cancer	0.000598	0.00147	CcSEcCtD
Levonorgestrel—Dermatitis—Carmustine—brain cancer	0.000597	0.00147	CcSEcCtD
Levonorgestrel—Headache—Carmustine—brain cancer	0.000594	0.00146	CcSEcCtD
Levonorgestrel—Vomiting—Temozolomide—brain cancer	0.000583	0.00144	CcSEcCtD
Levonorgestrel—Urticaria—Etoposide—brain cancer	0.000583	0.00144	CcSEcCtD
Levonorgestrel—Body temperature increased—Etoposide—brain cancer	0.00058	0.00143	CcSEcCtD
Levonorgestrel—Abdominal pain—Etoposide—brain cancer	0.00058	0.00143	CcSEcCtD
Levonorgestrel—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.000579	0.00386	CbGpPWpGaD
Levonorgestrel—Rash—Temozolomide—brain cancer	0.000578	0.00142	CcSEcCtD
Levonorgestrel—Dermatitis—Temozolomide—brain cancer	0.000577	0.00142	CcSEcCtD
Levonorgestrel—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000574	0.00383	CbGpPWpGaD
Levonorgestrel—Headache—Temozolomide—brain cancer	0.000574	0.00141	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—IRS2—brain cancer	0.000569	0.00379	CbGpPWpGaD
Levonorgestrel—ESR1—FOXM1 transcription factor network—CCND1—brain cancer	0.000566	0.00377	CbGpPWpGaD
Levonorgestrel—Nausea—Carmustine—brain cancer	0.000563	0.00139	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000556	0.0037	CbGpPWpGaD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.000552	0.00368	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000551	0.00367	CbGpPWpGaD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.000545	0.00363	CbGpPWpGaD
Levonorgestrel—Nausea—Temozolomide—brain cancer	0.000544	0.00134	CcSEcCtD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.00054	0.0036	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Etoposide—brain cancer	0.00054	0.00133	CcSEcCtD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.00054	0.00359	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000535	0.00357	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000527	0.00351	CbGpPWpGaD
Levonorgestrel—Asthenia—Etoposide—brain cancer	0.000526	0.0013	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.000519	0.00346	CbGpPWpGaD
Levonorgestrel—Pruritus—Etoposide—brain cancer	0.000519	0.00128	CcSEcCtD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000518	0.00345	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—ENO2—brain cancer	0.000512	0.00341	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.000508	0.00338	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000507	0.00338	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Etoposide—brain cancer	0.000502	0.00124	CcSEcCtD
Levonorgestrel—Dizziness—Etoposide—brain cancer	0.000485	0.00119	CcSEcCtD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000474	0.00316	CbGpPWpGaD
Levonorgestrel—Vomiting—Etoposide—brain cancer	0.000466	0.00115	CcSEcCtD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000465	0.0031	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—VAV1—brain cancer	0.000464	0.00309	CbGpPWpGaD
Levonorgestrel—Rash—Etoposide—brain cancer	0.000462	0.00114	CcSEcCtD
Levonorgestrel—Dermatitis—Etoposide—brain cancer	0.000462	0.00114	CcSEcCtD
Levonorgestrel—Headache—Etoposide—brain cancer	0.000459	0.00113	CcSEcCtD
Levonorgestrel—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.000459	0.00306	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000459	0.00306	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000457	0.00304	CbGpPWpGaD
Levonorgestrel—ESR1—FOXM1 transcription factor network—MYC—brain cancer	0.000454	0.00302	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000448	0.00298	CbGpPWpGaD
Levonorgestrel—ESR1—LKB1 signaling events—MYC—brain cancer	0.000445	0.00297	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000445	0.00296	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000442	0.00295	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.000439	0.00292	CbGpPWpGaD
Levonorgestrel—Nausea—Etoposide—brain cancer	0.000436	0.00107	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000434	0.00289	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000432	0.00288	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000431	0.00287	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—CCND1—brain cancer	0.000431	0.00287	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000428	0.00285	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—OR4C12—brain cancer	0.000427	0.00285	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—OR14C36—brain cancer	0.000427	0.00285	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000424	0.00283	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000422	0.00281	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000416	0.00277	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000413	0.00275	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000411	0.00274	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000409	0.00272	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—RELA—brain cancer	0.000405	0.0027	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000404	0.00269	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—CCND1—brain cancer	0.000403	0.00268	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—ERBB2—brain cancer	0.000403	0.00268	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	0.000399	0.00266	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—IL2—brain cancer	0.000395	0.00263	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000392	0.00261	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—ERBB2—brain cancer	0.00039	0.0026	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL2—brain cancer	0.000386	0.00257	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—CCND1—brain cancer	0.000385	0.00256	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—PDGFRA—brain cancer	0.00038	0.00253	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—CCND1—brain cancer	0.000376	0.0025	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000372	0.00248	CbGpPWpGaD
Levonorgestrel—ESR1—LKB1 signaling events—TP53—brain cancer	0.000366	0.00244	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—DTX2—brain cancer	0.000363	0.00242	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—ESR2—brain cancer	0.000363	0.00241	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—CCND1—brain cancer	0.000356	0.00237	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000352	0.00234	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000352	0.00234	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000352	0.00234	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000348	0.00232	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—STAT3—brain cancer	0.000348	0.00232	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000345	0.0023	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000343	0.00229	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000341	0.00227	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000339	0.00226	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—IRS2—brain cancer	0.000334	0.00222	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000328	0.00219	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.000324	0.00216	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000324	0.00216	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000319	0.00212	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000317	0.00211	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—EGFR—brain cancer	0.000316	0.00211	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000316	0.0021	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000315	0.0021	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—MYC—brain cancer	0.000309	0.00206	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—STAT3—brain cancer	0.000307	0.00205	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—EGFR—brain cancer	0.000302	0.00201	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000302	0.00201	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—MYC—brain cancer	0.000302	0.00201	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—ESR2—brain cancer	0.000276	0.00184	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PTCH2—brain cancer	0.000275	0.00183	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—EGFR—brain cancer	0.00027	0.0018	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000268	0.00179	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HES5—brain cancer	0.000267	0.00178	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000264	0.00176	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000262	0.00174	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000261	0.00174	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000261	0.00174	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STRADA—brain cancer	0.000259	0.00172	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000255	0.0017	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—OR4C12—brain cancer	0.000251	0.00167	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—OR14C36—brain cancer	0.000251	0.00167	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—TP53—brain cancer	0.000248	0.00165	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000248	0.00165	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000246	0.00164	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PIK3CG—brain cancer	0.000235	0.00156	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.00023	0.00153	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—ERBB2—brain cancer	0.000229	0.00152	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000227	0.00151	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000225	0.0015	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000224	0.00149	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000219	0.00146	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000217	0.00144	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ABR—brain cancer	0.000216	0.00144	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—DTX2—brain cancer	0.000213	0.00142	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—ESR2—brain cancer	0.000213	0.00142	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000212	0.00141	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GLI2—brain cancer	0.000209	0.00139	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000207	0.00138	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000203	0.00135	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000202	0.00134	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000201	0.00134	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000198	0.00132	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GLI1—brain cancer	0.000196	0.00131	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—DNMT1—brain cancer	0.000194	0.00129	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2C9—brain cancer	0.000192	0.00128	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000191	0.00127	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000191	0.00127	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SUFU—brain cancer	0.000186	0.00124	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000182	0.00121	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GFAP—brain cancer	0.000179	0.0012	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000178	0.00119	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000177	0.00118	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000175	0.00117	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—ESR2—brain cancer	0.000175	0.00116	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000174	0.00116	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000172	0.00114	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HEY1—brain cancer	0.00017	0.00113	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000168	0.00112	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000167	0.00111	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—DLL1—brain cancer	0.000167	0.00111	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NOTCH2—brain cancer	0.000165	0.0011	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—BSG—brain cancer	0.000164	0.00109	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000163	0.00109	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTCH2—brain cancer	0.000162	0.00108	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000159	0.00106	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—EGFR—brain cancer	0.000159	0.00106	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HES5—brain cancer	0.000156	0.00104	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STRADA—brain cancer	0.000152	0.00101	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	0.00015	0.000996	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—DNMT1—brain cancer	0.000148	0.000987	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000147	0.000978	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000144	0.000959	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SHH—brain cancer	0.000142	0.000945	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—IDH1—brain cancer	0.000141	0.000937	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—SIRT1—brain cancer	0.000141	0.000936	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TRPC6—brain cancer	0.000137	0.000911	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000135	0.0009	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PTCH1—brain cancer	0.000134	0.000896	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SMO—brain cancer	0.000134	0.000896	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000134	0.000892	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—ESR2—brain cancer	0.000133	0.000886	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000132	0.00088	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ABR—brain cancer	0.000127	0.000845	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NOTCH2—brain cancer	0.000126	0.000839	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GLI2—brain cancer	0.000122	0.000816	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GLI1—brain cancer	0.000115	0.000767	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000115	0.000763	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—MYC—brain cancer	0.000114	0.000762	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—DNMT1—brain cancer	0.000114	0.00076	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ENO2—brain cancer	0.000111	0.000741	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000111	0.000739	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SUFU—brain cancer	0.000109	0.000727	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH2—brain cancer	0.000107	0.000716	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SIRT1—brain cancer	0.000107	0.000713	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GFAP—brain cancer	0.000105	0.000701	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VAV1—brain cancer	0.000102	0.000682	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—ESR2—brain cancer	0.000102	0.000682	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HEY1—brain cancer	9.98e-05	0.000665	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—DLL1—brain cancer	9.79e-05	0.000652	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH2—brain cancer	9.7e-05	0.000646	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HES1—brain cancer	8.81e-05	0.000587	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—MYC—brain cancer	8.71e-05	0.00058	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PDGFRA—brain cancer	8.39e-05	0.000559	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SHH—brain cancer	8.32e-05	0.000554	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SIRT1—brain cancer	8.25e-05	0.000549	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SPP1—brain cancer	8.15e-05	0.000543	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TRPC6—brain cancer	8.03e-05	0.000535	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTCH1—brain cancer	7.89e-05	0.000526	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SMO—brain cancer	7.89e-05	0.000526	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IRS2—brain cancer	7.37e-05	0.000491	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—MYC—brain cancer	6.71e-05	0.000447	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CG—brain cancer	6.51e-05	0.000433	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APC—brain cancer	6.51e-05	0.000433	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH2—brain cancer	6.31e-05	0.00042	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VAV1—brain cancer	6.01e-05	0.000401	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2C9—brain cancer	5.61e-05	0.000374	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MYC—brain cancer	5.51e-05	0.000367	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HES1—brain cancer	5.17e-05	0.000345	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CG—brain cancer	5.1e-05	0.00034	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RELA—brain cancer	5.08e-05	0.000339	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ERBB2—brain cancer	5.05e-05	0.000336	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PDGFRA—brain cancer	4.92e-05	0.000328	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SPP1—brain cancer	4.78e-05	0.000318	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—BSG—brain cancer	4.77e-05	0.000318	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL2—brain cancer	4.58e-05	0.000305	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCND1—brain cancer	4.46e-05	0.000297	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CTNNB1—brain cancer	4.42e-05	0.000294	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IRS2—brain cancer	4.32e-05	0.000288	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MYC—brain cancer	4.19e-05	0.000279	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—IDH1—brain cancer	4.1e-05	0.000273	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—brain cancer	3.89e-05	0.000259	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STAT3—brain cancer	3.85e-05	0.000257	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CG—brain cancer	3.82e-05	0.000254	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APC—brain cancer	3.82e-05	0.000254	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MYC—brain cancer	3.58e-05	0.000238	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EGFR—brain cancer	3.5e-05	0.000233	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ENO2—brain cancer	3.24e-05	0.000216	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MYC—brain cancer	3.23e-05	0.000215	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RELA—brain cancer	2.98e-05	0.000199	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ERBB2—brain cancer	2.96e-05	0.000197	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—brain cancer	2.94e-05	0.000196	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL2—brain cancer	2.69e-05	0.000179	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCND1—brain cancer	2.62e-05	0.000174	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CTNNB1—brain cancer	2.59e-05	0.000173	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—brain cancer	2.28e-05	0.000152	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT3—brain cancer	2.26e-05	0.000151	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MYC—brain cancer	2.1e-05	0.00014	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EGFR—brain cancer	2.06e-05	0.000137	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—brain cancer	1.73e-05	0.000115	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CG—brain cancer	1.49e-05	9.92e-05	CbGpPWpGaD
